DeFi Capital Markets, Inc.: Form 10-Q for the period ended Dec 31, 2019
Filed with the SEC on Feb 19, 2020 and accepted by EDGAR at Feb 19, 2020, 16:39 ET.
Management's discussion and analysis
As filed, 20,572 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
As used throughout this Report, “we,” “our,” “the Company” “USI” and similar words refers to Universal Security Instruments, Inc.
Forward-Looking Statements
This Quarterly Report on Form 10-Q contains certain forward-looking statements reflecting our current expectations with respect to our operations, performance, financial condition, and other developments. These forward-looking statements may generally be identified by the use of the words “may”, “will”, “believes”, “should”, “expects”, “anticipates”, “estimates”, and similar expressions. These statements are necessarily estimates reflecting management’s best judgment based upon current information and involve a number of risks and uncertainties. We caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made, and readers are advised that various factors could affect our financial performance and could cause our actual results for future periods to differ materially from those anticipated or projected. While it is impossible to identify all such factors, such factors include, but are not limited to, those risks identified in our periodic reports filed with the Securities and Exchange Commission.
overview
We are in the business of marketing and distributing safety and security products which are primarily manufactured through our 50%-owned Hong Kong Joint Venture. Our financial statements detail our sales and other operational results only, and report the financial results of the Hong Kong Joint Venture using the equity method. Accordingly, the following discussion and analysis of the three and nine month periods ended December 31, 2019 and 2018 relate to the operational results of the Company. A discussion and analysis of the Hong Kong Joint Venture’s operational results for these periods is presented below under the heading “Joint Venture.”
The Company has developed new products based on new smoke and gas detection technologies, with what the Company believes are improved sensing technology and product features. To date we have applied for thirteen patents on these new technologies and features. We have been granted ten patents (including six for new technologies and features). Most of our new technologies and features have been trademarked under the trade name IoPhic.
Changes in international trade duties and other aspects of international trade policy, both in the U.S. and abroad, could materially impact the cost of our products. All of our products are imported from the Peoples Republic of China (PRC). To date, only certain of our products such as Carbon Monoxide and Photoelectric alarms, and USB devices, have been subjected to tariffs of 25%. We are monitoring these developments and will determine our strategies as additional information becomes available. Any increase in tariffs that is not offset by an increase in our sales prices could have an adverse effect on our business, financial position, results of operations or cash flows.
Results of Operations
Three Months Ended December 31, 2019 and 2018
Sales. Net sales for the three months ended December 31, 2019 were $3,223,678 compared to $4,491,862 for the comparable three months in the prior year, a decrease of $1,268,184 (28.2%). Sales decreased principally due to reduced sales for rebuilding projects in Puerto Rico due to the delay in emergency management funding and to resistance to the pass through of increased costs associated with tariffs on goods imported from the Peoples Republic of China.
Gross Profit Margin. Gross profit margin is calculated as net sales less cost of goods sold expressed as a percentage of net sales. Our gross profit margin was 23.9% and 23.6% of sales for the quarters ended December 31, 2019 and 2018, respectively.
Expenses. Selling, general and administrative expenses were $1,083,913 for the three months ended December 31, 2019, compared to $1,120,585 for the comparable three months in the prior year. As a percentage of net sales, these expenses increased to 33.6% for the three month period ended December 31, 2019, from 24.9% for the 2018 period. These expenses increased as a percentage of net sales since selling, general, and administrative expenses do not fluctuate in direct proportion to sales.
Research and development expenses were $169,768 for the three month period ended December 31, 2019 compared to $86,461 for the comparable quarter of the prior year, an increase of $83,307 (96.4%). The primary reason for the increase is amounts paid to engineering consultants for services towards meeting revised smoke alarm testing standards proposed for the year 2020.
Interest Expense. Our interest expense was $119,308 for the quarter ended December 31, 2019, compared to interest expense of $115,924 for the quarter ended December 31, 2018. Interest expense is dependent upon the total amounts borrowed on average from the Factor and on extended trade payables due to the Hong Kong Joint Venture and on interest rates which vary with the prime rate of interest.
Net Loss. We reported a net loss of $1,011,833 for the quarter ended December 31, 2019, compared to a net loss of $516,993 for the corresponding quarter of the prior fiscal year, a $494,840 (95.7%) increase in the net loss. The primary reason for the increase in the net loss is the decrease in sales as discussed above, the imposition of tariffs, and the increase in our net loss of the Hong Kong Joint Venture.
Nine Months Ended December 31, 2019 and 2018
Sales. Net sales for the nine months ended December 31, 2019 were $11,189,238 compared to $13,064,110 for the comparable nine months in the prior period, a decrease of $1,874,872 (14.3%). Sales decreased principally due to reduced sales for rebuilding projects in Puerto Rico due to the delay in emergency management funding and to resistance to the pass through of increased costs associated with tariffs on goods imported from the Peoples Republic of China.
Gross Profit Margin. The gross profit margin is calculated as net sales less cost of goods sold expressed as a percentage of net sales. The Company’s gross profit margin was 27.8% for the nine month period ended December 31, 2019 and 28.8% for the nine month period ended December 31, 2018. The decrease in gross profit margin was primarily due to the imposition of tariffs and the mix of products sold to differing customers.
Expenses. Selling, general and administrative expenses were $3,455,661 for the nine months ended December 31, 2019 compared to $3,416,924 for the comparable nine months in the prior year. As a percentage of sales, these expenses were 30.9% for the nine month period ended December 31, 2019 and 26.2% for the comparable 2018 period. These expenses increased as a percentage of net sales since selling, general, and administrative expenses do not fluctuate in direct proportion to sales.
Research and development expenses were $487,144 for the nine months ended December 31, 2019 compared to $360,766 for the comparable period of the prior year, an increase of $126,378 (35.0%). The primary reason for the increase is amounts paid to engineering consultants for services towards meeting revised smoke alarm testing standards proposed for the year 2020.
Interest Expense. Our interest expense was $332,336 for the nine months ended December 31, 2019, compared to interest expense of $293,277 for the nine months ended December 31, 2018. Interest expense is dependent upon the total amounts borrowed on average from the Factor and on extended trade payables due to the Hong Kong Joint Venture and on interest rates which vary with the prime rate of interest.
Net Loss. We reported a net loss of $2,321,601 for the nine months ended December 31, 2019 compared to a net loss of $1,077,150 for the corresponding period of the prior fiscal year, an increase in the net loss of $1,244,451 (115.5%). The primary reason for the increase in the net loss is the decrease in sales as discussed above, the imposition of tariffs, and the increase in our net loss of the Hong Kong Joint Venture.
Joint Venture
Net Sales. Net sales of the Joint Venture for the three and nine months ended December 31, 2019 were $1,680,617 and $6,600,373 respectively, compared to $3,218,878 and $11,175,101, respectively, for the comparable period in the prior fiscal year. The 47.8% and 40.9% decreases in net sales by the Joint Venture for the respective three and nine month periods are due to decreased sales to the Company and to unaffiliated customers.
Gross Profit Margin. Gross margins of the Joint Venture for the three month period ended December 31, 2019 decreased to (0.9)% from 13.1% for the 2018 corresponding period. For the nine month period ended December 31, 2019, gross margins were 5.4% compared to 13.8% for the same period of the prior year. Gross margins depend on sales volume of various products, with varying margins. Lower sales and manufacturing production during the December 31, 2019 period do not allow the full absorption of fixed factory costs and negatively impact gross margins. In addition, foreign currency exchange gains and/or losses and changes in inventory reserves impact gross margins.
Expenses. Selling, general and administrative expenses were $984,358 and $3,068,158 respectively, for the three and nine month periods ended December 31, 2019, compared to $1,022,455 and $3,265,526 in the prior year’s respective periods. As a percentage of sales, expenses were 58.6% and 46.5% for the three and nine month periods ended December 31, 2019, compared to 31.8% and 29.2% for the three and nine month periods ended December 31, 2018. The changes in selling, general and administrative expense as a percent of sales for the three and nine month periods were primarily due to costs that do not change at the same rate as changes in sales volume.
Interest Income. Interest income on assets held for investment was $64,501 and $293,375 respectively, for the three and nine month periods ended December 31, 2019, compared to interest income of $67,287 and $281,976, respectively, for the prior year’s periods. Interest income is dependent on yields and on the average balance of assets held for investment and amounts due from the Company.
Net Loss. Net losses for the three and nine months ended December 31, 2019 were $902,247 and $2,399,054 respectively, compared to net losses of $426,316 and $1,175,720, respectively, in the comparable periods last year. The decrease in net earnings for the three and nine month periods ended December 31, 2019 is due primarily to decreased sales to the company and to unaffiliated customers.
Liquidity. Cash needs of the Joint Venture are currently met by funds generated from the sale of assets held for investment. During the nine months ended December 31, 2019, working capital decreased by $2,294,585 from $11,608,698 on March 31, 2019 to $9,314,113 on December 31, 2019.
Management Plans and Liquidity
The Company had net losses of $2,321,601 for the nine months ended December 31, 2019 and $1,347,986 and $2,262,310 for the years ended March 31, 2019 and 2018, respectively. Furthermore, as of December 31, 2019, working capital (computed as the excess of current assets over current liabilities) decreased by $1,321,347 from $2,354,313 at March 31, 2019, to $1,032,966 at December 31, 2019.
Our short-term borrowings to finance operating losses, trade accounts receivable, and foreign inventory purchases are provided pursuant to the terms of our Factoring Agreement with Merchant Factors Corporation (Merchant or Factor). Borrowings under our Factoring Agreement bear interest at prime plus 2% and are secured by trade accounts receivable and inventory. Advances from Merchant are at the sole discretion of Merchant based on their assessment of the Company’s receivables, inventory and financial condition at the time of each request for an advance. The unused availability of this facility totaled approximately $466,000 at December 31, 2019. In addition, we have secured extended payment terms for purchases up to $4,000,000 from our Hong Kong Joint Venture for the purchase of sealed battery alarms. These amounts are unsecured, bear interest at 5.5% per annum on amounts outstanding at November 13, 2019 and 5.125% per annum on amounts outstanding thereafter, and provide for repayment terms of 120 days for each purchase. The balance outstanding under this agreement at December 31, 2019 was $5,616,296 with $3,939,884 of this amount being beyond agreed repayment terms. The Hong Kong Joint Venture has provided discretionary approval to allow the Company to exceed the agreed upon repayment terms and has indicated it has no plans or intentions that would materially impact the financial position, operations, or cash flows of the Company.
The Company has a history of sales that are insufficient to generate profitable operations, and has limited sources of financing. Management’s plan in response to these conditions includes increasing sales resulting from the delivery of the Company’s line of sealed battery ionization smoke alarms, carbon monoxide products, and ground fault circuit interrupters. Notwithstanding the above, the Company has seen substantial increases in its cost structure including the imposition of tariffs on the importation of its products from the Peoples Republic of China and in interest incurred on its credit facilities through December 31, 2019. In addition, sales revenue for the nine months ended December 31, 2019 has not met management’s expectations. Though no assurances can be given, if management’s plan is successful over the next twelve months, the Company anticipates that it should be able to meet its cash needs. Cash flows and credit availability from the Factor and the Hong Kong Joint Venture is expected to be adequate to fund operations for one year from the issuance date of this report.
Operating activities provided cash of $309,795 for the nine months ended December 31, 2019. This was primarily due to a decrease in accounts receivable and amounts due from factor of $885,657, an increase in accounts payable and accrued expenses of $301,966, a decrease in inventories, prepaid expenses and other of $287,955,and offset by a net loss of $2,321,601. The net loss includes a non-cash loss from the investment in the Hong Kong Joint Venture of $1,151,627. Operating activities provided cash of $99,629 for the nine months ended December 31, 2018. This was primarily due to an increase in accounts payable and accrued expenses of $2,250,962 and offset by a net loss of $1,077,150 and an increase in accounts receivable and amounts due from factor of $178,028, and an increase in inventories, prepaid expenses and other of $1,677,649. The net loss includes a non-cash loss from the investment in the Hong Kong Joint Venture of $764,197.
There were no investing activities for the nine months ended December 31 2019 or 2018
Financing activities used cash of $506,930 during the nine months ended December 31, 2019 and used cash of $83,442 during the nine months ended December 31, 2018, which is comprised of repayments net of advances on the line of credit from our factor.
Critical Accounting Policies
In the notes to the consolidated financial statements, and in “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in our Form 10-K, we have disclosed those accounting policies that we consider to be significant in determining our results of Operations and financial condition. Except as disclosed below, there have been no material changes to those policies that we consider to be significant since the filing of our Form 10-K. The accounting principles used in preparing our unaudited condensed consolidated financial statements conform in all material respects to accounting principles generally accepted in the U.S.
In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which sets out the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract (i.e., lessees and lessors). The new standard requires lessees to apply a dual approach, classifying leases as either financing or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification determines whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of 12 months or less are accounted for similar to previous guidance for operating leases with the election of the practical expedient. The new standard requires lessors to account for leases using an approach that is substantially equivalent to previous guidance for sales-type leases, direct financing leases and operating leases. The Company adopted the standard on April 1, 2019, the date it became effective for public companies based on the Company’s fiscal year, using the modified retrospective approach whereby the cumulative effect of adoption was recognized on the adoption date and prior periods were not restated. There was no net cumulative effect adjustment to the accumulated deficit as of April 1, 2019 as a result of this adoption. Upon adoption, the Company elected the package of practical expedients permitted within the standard, which among other things, allows for the carryforward of historical lease classification. The Company also elected the practical expedient provided in a subsequent amendment to the standard that removed the requirement to separate lease and non-lease components, provided certain conditions were met.
The impact of the adoption of this guidance on the Company’s condensed consolidated financial statements is discussed below:
The Company is a lessee in lease agreements for office space. Certain of the Company’s leases contain provisions that provide for one or more options to renew at the Company’s sole discretion. The Company’s leases are comprised of fixed lease payments, with its real estate leases including lease payments subject to a rate or index which may be variable. Certain real estate leases also include executory costs such as common area maintenance (non-lease component). As a practical expedient permitted under ASC 842, the Company has elected to account for the lease and non-lease components as a single lease component. Lease payments, which may include lease components and non-lease components, are included in the measurement of the Company’s lease liabilities to the extent that such payments are either fixed amounts or variable lease amounts based on a rate or index (fixed in substance) as stipulated in the lease contract.
None of the Company’s lease agreements contain any residual value guarantees or material restrictive covenants. As a result of the Company’s election of the package of practical expedients permitted within ASC 842, which among other things, allows for the carryforward of historical lease classification, all of the Company’s lease agreements in existence at the date of adoption that were classified as operating leases under ASC 840 have been classified as operating leases under ASC 842. Lease expense for payments related to the Company’s operating leases is recognized on a straight-line basis over the related lease term, which includes options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option.
Right-of-use assets represent the Company’s right to use an underlying asset during the lease term and lease liabilities represent the Company’s obligation to make lease payments as specified in the lease. Right-of-use assets and lease liabilities related to the Company’s operating leases are recognized at the lease commencement date based on the present value of the remaining lease payments over the lease term and amount to $475,538 at the date of adoption. When the Company’s leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available surrounding the Company’s borrowing rates at the lease commencement date in determining the present value of lease payments. The right-of use asset also includes any lease payments made at or before lease commencement less any lease incentives.
Controls and procedures
As filed, 2,231 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
We maintain a system of disclosure controls and procedures (as such item is defined in Rules 13a – 15(e) and 15d – 15(e) of the Exchange Act) that is designed to provide reasonable assurance that information, which is required to be disclosed by us in the reports that we file or submit under the Securities and Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission, and is accumulated and communicated to management in a timely manner. Our Chief Executive Officer and Chief Financial Officer have evaluated this system of disclosure controls and procedures in accordance with applicable Securities and Exchange Commission guidance as of the end of the period covered by this quarterly report, and have concluded that disclosure controls and procedures were not effective because of the material weakness in internal control over financial reporting as discussed below.
Material weaknesses arose in our oversight of the accounting function as well as the disclosure controls and procedures of the Hong Kong Joint Venture (HKJV). The HKJV is a material component of the Company’s consolidated financial statements. With respect to our internal control over financial reporting, these matters above are being discussed among management, the HKJV and our Audit Committee. Management intends to review, revise and improve our internal controls over financial reporting until the material weaknesses in internal control over financial reporting are eliminated. Management’s specific remediation to address these material weaknesses will include among other items: a) enhancing corporate financial reporting resources, particularly for oversight, and process improvement, and b) reinforcing internal policies with all process owners.
Changes in Internal Control over Financial Reporting. There have not been any changes in our internal control over financial reporting that occurred during the quarter ended December 31, 2019 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2019-10-01 to 2019-12-31 | $3.2m | us-gaap:Revenues |
| Revenue | 9 months2019-04-01 to 2019-12-31 | $11.2m | us-gaap:Revenues |
| Gross profit | 3 months2019-10-01 to 2019-12-31 | $770.0k | us-gaap:GrossProfit |
| Gross profit | 9 months2019-04-01 to 2019-12-31 | $3.1m | us-gaap:GrossProfit |
| Research and development | 3 months2019-10-01 to 2019-12-31 | $169.8k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2019-04-01 to 2019-12-31 | $487.1k | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2019-10-01 to 2019-12-31 | $1.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2019-04-01 to 2019-12-31 | $3.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2019-10-01 to 2019-12-31 | −$483.7k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2019-04-01 to 2019-12-31 | −$837.6k | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2019-10-01 to 2019-12-31 | $119.3k | us-gaap:InterestExpense |
| Interest expense | 9 months2019-04-01 to 2019-12-31 | $332.3k | us-gaap:InterestExpense |
| Net income | 3 months2019-10-01 to 2019-12-31 | −$1.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months2019-04-01 to 2019-12-31 | −$2.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2019-10-01 to 2019-12-31 | −$0.44 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 9 months2019-04-01 to 2019-12-31 | −$1.00 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 9 months2019-04-01 to 2019-12-31 | $309.8k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2019-12-31 | $177.3k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2019-12-31 | $9.0m | us-gaap:AssetsCurrent |
| Total assets | At period end2019-12-31 | $16.5m | us-gaap:Assets |
| Current liabilities | At period end2019-12-31 | $8.0m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2019-12-31 | $8.3m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001104659-20-022854. Last ingested by Listed: Nov 4, 2026, 06:09 ET. Listed shows no prices and gives no investment advice.